NIPH Clinical Trials Search

JAPANESE
国立保健医療科学院
UMIN ID: UMIN000054174

Registered date:17/04/2024

Effectiveness of hypertensive drugs for the treatment of bipolar disorder

Basic Information

Recruitment status Pending
Health condition(s) or Problem(s) studiedBipolar disorder
Date of first enrollment2024/04/17
Target sample size50000
Countries of recruitmentJapan
Study typeObservational
Intervention(s)

Outcome(s)

Primary OutcomeTime to psychiatric hospitalization: The follow-up will start at the next day of the index date for outpatients and the next day of the discharge date fotime will be reset when an outcome event occurs and re-start follow-up at the next day of the discharge date. The follow-up will end at death or on May 31/2023.
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum20years-old
Age maximumNot applicable
GenderMale and Female
Include criteria
Exclude criteriaNot applicable.

Related Information

Contact

public contact
Name Tadafumi Kato
Address 2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan 113-8421
Telephone +81-3-3813-3111
E-mail tadafumi.kato@juntendo.ac.jp
Affiliation Juntendo University Department of Psychiatry and Behavioral Science, Juntendo University Graduate School of Medicine
scientific contact
Name Tadafumi Kato
Address 2-1-1 Hongo, Bunkyo-ku, Tokyo, Japan
Telephone +81-3-5802-1070
E-mail tadafumi.kato@juntendo.ac.jp
Affiliation Juntendo University Department of Psychiatry and Behavioral Science, Juntendo University Graduate School of Medicine